WO1996024686A2 - Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques - Google Patents
Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques Download PDFInfo
- Publication number
- WO1996024686A2 WO1996024686A2 PCT/FR1996/000202 FR9600202W WO9624686A2 WO 1996024686 A2 WO1996024686 A2 WO 1996024686A2 FR 9600202 W FR9600202 W FR 9600202W WO 9624686 A2 WO9624686 A2 WO 9624686A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probe
- sequence
- oligonucleotide
- listeria
- species
- Prior art date
Links
- 239000000523 sample Substances 0.000 title claims abstract description 144
- 241000186781 Listeria Species 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 50
- 238000009396 hybridization Methods 0.000 title claims abstract description 38
- 230000014670 detection of bacterium Effects 0.000 title description 3
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 47
- 241000894007 species Species 0.000 claims abstract description 47
- 241000894006 Bacteria Species 0.000 claims abstract description 27
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002773 nucleotide Substances 0.000 claims description 33
- 125000003729 nucleotide group Chemical group 0.000 claims description 33
- 150000007523 nucleic acids Chemical class 0.000 claims description 28
- 241000186779 Listeria monocytogenes Species 0.000 claims description 27
- 108020004707 nucleic acids Proteins 0.000 claims description 27
- 102000039446 nucleic acids Human genes 0.000 claims description 27
- 230000000295 complement effect Effects 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- 241000186806 Listeria grayi Species 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 241000186805 Listeria innocua Species 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 239000000700 radioactive tracer Substances 0.000 claims description 3
- 241000186807 Listeria seeligeri Species 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 30
- 108020004418 ribosomal RNA Proteins 0.000 abstract description 21
- 108020004414 DNA Proteins 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 108020005097 23S Ribosomal RNA Proteins 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 238000010494 dissociation reaction Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 239000013615 primer Substances 0.000 description 5
- 238000010839 reverse transcription Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 241000206605 Brochothrix Species 0.000 description 3
- 241000206604 Brochothrix thermosphacta Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000206603 Brochothrix campestris Species 0.000 description 2
- 241001112695 Clostridiales Species 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 101710164436 Listeriolysin O Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 108020001027 Ribosomal DNA Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 238000010396 two-hybrid screening Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- -1 6-aminohexyl group Chemical group 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000937413 Axia Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101100378273 Brachyspira hyodysenteriae acpP gene Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 101150038414 LAP gene Proteins 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186780 Listeria ivanovii Species 0.000 description 1
- 101100098690 Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) hly gene Proteins 0.000 description 1
- 241000186814 Listeria welshimeri Species 0.000 description 1
- 241001112727 Listeriaceae Species 0.000 description 1
- 206010024641 Listeriosis Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101800000874 Small capsid protein Proteins 0.000 description 1
- 101800000996 Small capsid protein precursor Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000006872 enzymatic polymerization reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 101150021605 hlyA gene Proteins 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Definitions
- the present invention relates to the field of detection and / or amplification techniques, using oligonucleotide probes or primers, and their application to the search for the presence or identification of bacteria of the genus Listeria.
- Listeria are Gram + bacteria belonging to the family of Listeriaceae, which is subdivided into two genera the genus Listeria and the genus Brochothrix (Collins et al, 1991, International Journal of Systematic Bacteriology, 41, 240-246)
- the genus Listeria groups the following bacterial species Listeria monocytogenes, Listeria innocua, Listeria seeligert, Listeria welshimeri, Listeria ivanovu, Listeria murrayi and Listeria grayi
- Listeria monocytogenes has a pathogenic capacity for humans This species is particularly responsible in humans for severe pathologies such as meningoencephalitis, septicemia or abortion
- the species Listeria monocytogenes has been recognized as the agent responsible for several epidemics of food poisoning, notably in Canada in 1981, in the United States from 1983 to 1985, in Switzerland from 1983 to 1987 and very recently in France in 1992 and 1993
- the mortality rate associated with these pidripartis is very high, about a third of
- the present invention overcomes the aforementioned drawbacks for demonstrating the presence of bacteria of the genus Listeria, and more particularly of the species Listeria monocytogenes, by using a genetic marker in a detection process by nucleic acid hybridization , combining specificity, sensitivity and speed
- RNA molecules Bacterial ribosomes contain at least three distinct RNA molecules called 5S, 16S and 23S rRNAs. Historically, these names have been chosen by reference to their sedimentation rate, which is related to the size of these RNA molecules
- the ribosomal RNA (rRNA) of bacteria can be used as a target.
- rRNA ribosomal RNA
- nucleic acid extracted from bacteria means either the total nucleic acid, or the ribosomal RNA, in particular the 23S rRNA, or the genomic DNA, or even the DNA obtained from the reverse transcription of 23 S ribosomal RNA;
- nucleotide fragment or an "oligonucleotide” are two synonymous terms designating a sequence of nucleotide patterns characterized by the informational sequence of natural (or possibly modified) nucleic acids and capable of hybridizing, like natural nucleic acids, with a nucleotide fragment
- the chain may contain nucleotide motifs with a structure different from that of natural nucleic acids.
- a nucleotide fragment (or oligonucleotide) can contain, for example, up to 100 nucleotide units. It generally contains at least 10, and in particular at least 12 nucleotide units and can be obtained from a natural nucleic acid molecule and / or by genetic recombination and / or by chemical synthesis,
- a nucleotide motif is derived from a monomer which can be a natural nucleotide of nucleic acid, the constituent elements of which are a sugar, a phosphate group and a nitrogenous base; in DNA the sugar is deoxy-2-ribose, in RNA the sugar is ribose; depending on whether it is DNA or RNA, the nitrogen base is chosen from adenine, guanine, uracil, cytosine, thymine; or the monomer is a nucleotide modified in at least one of the three constituent elements; by way of example, the modification can take place either at the base level, with modified bases such as inosine, methyl-5-deoxycytidine, deoxyuridine, dimethylamino-5-deoxyuridine, diamino-2,6- purine, bromo-5-deoxyuridine or any other modified base capable of hybridization, either at the sugar level, not for example the replacement of at least one deoxyribose by a
- hybridization means the process during which, under appropriate conditions, two nucleotide fragments having sequences sufficiently
- hybridization conditions are determined by "stringency", that is to say the rigor of the operating conditions. Hybridization is all the more specific as it is performed at higher stringency. Stringency is a function in particular of the base composition of a probe / target duplex, as well as by the degree of mismatch between two nucleic acids. The stringency can also be a function of the parameters of the hybridization reaction, such as the concentration and the type of ionic species present in the hybridization solution, the nature and the concentration of denaturing agents and / or the temperature of hybridization. The stringency of the conditions under which a hybridization reaction must be carried out depends in particular on the probes used.
- the temperature for the hybridization reaction is between about 20 and 65 ° C, in particular between 35 and 65 ° in saline at a concentration of about 0.8 to 1M .
- probe is a nucleotide fragment comprising for example from 10 to
- nucleotide motifs in particular from 12 to 35 nucleotide motifs, having a specificity of hybridization under determined conditions to form a hybridization complex with a target nucleic acid having, in the present case, a nucleotide sequence comprised either in a ribosomal RNA , either in DNA obtained by reverse transcription of said ribosomal RNA, or in DNA (here called ribosomal DNA or rDNA) in which said ribosomal RNA is the transcription product; a probe can be used for diagnostic purposes (in particular capture or detection probes) or for therapy purposes,
- a "capture probe” is immobilized or immobilizable on a solid support by any suitable means, for example by covalence, by adsorption, or by direct synthesis on a solid support (see in particular patent application WO 92 10092) - a "detection probe" can be marked by means of a marker chosen for example from radioactive isotopes, enzymes, in particular enzymes capable of acting on a chromogenic, fluorigenic or luminescent substrate (in particular a peroxidase or a phosphatase alkaline), chromophoric chemical compounds, chromogenic, fluorigenic or luminescent compounds, nucleotide base analogs, and iigands such as biotin,
- a “primer” is a probe comprising for example from 10 to 100 nucleotide units and having a specificity of hybridization under conditions determined for the initiation of an enzymatic polymerization, for example in an amplification technique such as PCR (Polymerase Chain Reaction), in a sequencing process, in a reverse transcription method, etc.
- the probes according to the invention can be used, for diagnostic purposes, in the search for the presence or absence of a target nucleic acid in a sample, according to all the known hybridization techniques and in particular the techniques of point deposit on filter, called “dot-blot” (MANIATIS et al, Molecular Cloning, Cold Spring Harbor, 1982), DNA transfer techniques called “Southern blot” (SOUTHERN. EM, J. Mol.
- the technique is used sandwich, with a capture probe and / or a detection probe, said probes being capable of hybridizing with two different regions of the target nucleic acid, and at least one of said probes (generally the detection probe) being able to hybridize with a target region that is specific to the species or group of species sought, it being understood that the capture probe and the detection probe must have nucleotide sequences at least partially different.
- the nucleotide probes of the invention can be used in conventional hybridization methods
- the nucleic acid to be detected can be DNA (possibly obtained after amplification) or RNA.
- the target nucleic acid can be obtained by extraction, according to known methods, from the nucleic acids of a sample to be examined.
- the denaturation of a double-stranded nucleic acid can be carried out by known methods of chemical, physical or enzymatic denaturation, and in particular by heating to an appropriate temperature, above 80 ° C.
- the demonstration of the presence of a given Listeria species requires the use of probes allowing the detection of a point mutation. For this, it is advisable to operate with probes of a predetermined length (number of nucleotide units), under conditions which are themselves predetermined. Further details are given below, with particular reference to the sandwich hybridization method which constitutes one of the most practical hybridization methods currently.
- This method comprises contacting a first probe fixed on a solid support with a solution containing the nucleic acid to be analyzed, and bringing said support into contact with the detection probe, incubating the mixture obtained, rinsing of the support, to remove the constituents which are not fixed on the support by specific hybridization, and the qualitative or quantitative detection, using a revelation reaction of the marker fixed on the support, of the fixed detection probe.
- the revelation of the presence of the marker can be carried out for example by colorimetry, fluorescence or luminescence.
- the capture probe is brought into contact with the sample and with the detection probe can be carried out sequentially, possibly with intermediate rinsing of the support. It is also possible to operate by placing the capture probe fixed on the support in simultaneous or almost simultaneous contact with a solution containing the sample and the detection probe which can be added as a mixture or separately
- the incubation and subsequent washing stages, which constitute the key stages of the sandwich hybridization process, are each carried out at a constant temperature which can for example be included in the range mentioned above (see “Definitions”).
- nucleic acid hybrids have a dissociation temperature which depends on the number of bases hybridized (the temperature increases with the size of the hybrid) and which also depends on the nature of the bases hybridized and, for each hybridized base, of the nature of the adjacent bases.
- the dissociation of the hybrids occurs over a temperature interval of a few degrees and can be easily determined, for example by U V spectroscopy. It is possible to determine experimentally the half-dissociation temperature of the hybrid formed by a given probe with the target of complementary sequence, by simple routine experiments.
- the hybridization temperature used in the sandwich hybridization technique must obviously be chosen below the semi-dissociation temperature. More exactly, we operate at a temperature lower than the semi-dissociation temperature of the least stable hybrid. among the two hybrids formed by the target with a pan the capture probe and on the other hand the detection probe, so that the two hybrids are stable at the temperature at which one operates A point mutation, i.e.
- the subject of the invention is therefore a single-stranded oligonucleotic, characterized in that it is chosen from oligonucleotides, having at least 12 nucleotide units, the sequence of which is included in one of the sequences (a 1 ) to (a 10 ) from the following list
- oligonucleotides of the invention some can be used to characterize a species or a group of species of the genus Listeria. These are in particular the oligonucleotides defined using the sequences (b 1 ) to (bis) and (c 1 ) to (c 1 4 ) below.
- the invention relates in particular to an oligonucleotide as defined above, characterized in that it comprises a sequence of at least five consecutive nucleotide motifs included in a sequence included inside the square brackets appearing in the sequences (b 1 ) to (b 15 ) from the following list:
- the invention relates in particular to an oligonucleotide as defined above, characterized in that its sequence is included in one of the sequences (c 1 ) to (e 14 ) below
- oligonucleotides of the invention some can be used as a probe making it possible to detect any bacterium of the genus Listeria. These include
- oligonucleotides defined using the sequences (d 1 ) to (d 6 ) below.
- the invention therefore also relates to an oligonucleotide as defined above, characterized in that its sequence is included in one of the following sequences (d 1 ) to (d 6 ):
- the oligonucleotides of the invention can be immobilized on a solid support (this is notably the case with a capture probe) or labeled with a tracer agent (detection probe) .
- the subject of the invention is also a method for determining the presence or absence of at least one bacterium of the genus Listeria, in a sample containing or capable of containing nucleic acids of at least one such bacterium, according to a method in which said sample is brought into contact with at least one nucleic probe, then the formation or absence of formation of a hybridization complex between said probe and the nucleic acid of the sample, characterized in that the said probe is an oligonucleotide chosen from those which have been defined previously.
- nucleic probes For the determination of the presence or absence of a species or a group of species of bacteria of the genus Listeria, it is possible to use as nucleic probes on the one hand a first probe as defined above and on the other share a probe as defined by one of the sequences (b 1 ) to (b 15 ) or (c 1 ) to (e 14 ), it being understood that said first and second probes are capable of hybridizing with non-overlapping regions of rRNA 23 (or its complement) of a bacteria of the genus Listeria.
- the first probe is for example immobilized on a solid support and the second probe is labeled with a tracer agent.
- o can use as probe at least one oligonucleotide as defined by the sequences (d 1 ) to
- a specific probe of the genus Listeria (included in one of the sequences (d 1 ) to (d) can be used to determine the bacteria which have just been mentioned. 6 )) in combination with the specific sequences q have just been indicated.
- a two probe system is used for the determination of the presence or absence of Listeria monocytogenes. , in particular in a process characterized by the fact
- one of the probes has a sequence included in the sequence (b 1 ), (b 10 ), (b 14 ) or (b 15 ) and the other probe a sequence included in the sequence (b 4 ),
- oligonucleotides which have been defined above can also be used as nucleotide primers for the synthesis of a nucleic acid in the presence of a polymerase in a manner known per se, and in particular in amplification methods using such a synthesis in the presence of '' a polymerase (PCR, RT-PCR, etc.)
- the oligonucleotides of the invention can in particular be used as primers for the reverse reverse transcription specific for a 23 S ribosomal RNA sequence of at least one species or at least one group of species of the Listeria genus to obtain a sequence of corresponding complementary DNA
- a reverse transcription may constitute the first stage of an RT-PCR, the next stage being the PCR amplification of the complementary DNA obtained.
- oligonucleotides can also be used as primers, in particular for the amplification specific by polymerase chain reaction of the rDNA sequence complementary to a 23 S ribosomal RNA sequence of at least one species or at least one group of species of the genus Listeria
- the oligonucleotides defined above may also be used as therapy probes to treat infections caused by at least one species or group of species of bacteria of the genus Listeria
- These probes s of therapy capable of hybridizing to 23 S ribosomal RNA and / or to the genomic DNA of said bacteria can block the phenomena of translation and / or transcription and / or replication
- the principle of gene therapy methods is known and is based in particular on the use of a probe corresponding to an anti-sense strand the formation of a hybrid between the probe and the sense strand is capable of disturbing at least one of the steps of decrypting genetic information
- the sequencing was carried out according to the following steps: extraction of the DNA from the strains by the method of Sjöbring et al. (1990 Polymerase chain reaction for detection of Mycobacterium tuberculosis J Clin. Microbiol. 28 (10) .2200-2204), PCR amplification of 23S ribosomal DNA using eubacterial primers defined in the zones
- R means G or A
- This step allowed the amplification of 3 zones of approximately 1kb making it possible to cover the entire 23 S target and which were sequenced on each of the 2 strands by the chain termination method on an Applied Biosystems ABI 360 sequencer ( Sanger et al., Proc. Natl Acad Sci USA, 1977, 74 5463-5467)
- This probe was used as a detection probe in a sandwich hybridization test
- RNA from Gram + bacteria was extracted according to the basic protocol for the extraction of RNA from Gram + bacteria described in "Current Protocols in Molecular Biology" 1987, Ausubel FM et al., Wiley interscience, New York.
- a microtiter plate (Nunc 439454) is deposited a solution of 1 ng / ⁇ l of the capture oligonucleotide, the 5 'end of which is coupled with the reagent Aminolink 2 (registered trademark, Applied Biosystems, Foster city, California) in 3X PBS (0.45 M NaCl; 0.15 M sodium phosphate; pH 7.0). The plate is incubated for 2 h at 37 ° C.
- the Aminolink 2 reagent makes it possible to add an arm comprising a 6-aminohexyl group to the 5 ′ end of the probe.
- the target (10 ⁇ l of total RNA) mixed with 40 ⁇ l of salmon PBS buffer (PBS-3X + salmon sperm DNA 10 ⁇ g / ml (Sigma D 9156) is deposited in the well in the presence of 50 ⁇ l of a solution of the oligonucleotide-peroxidase conjugate, constituting the detection probe, at a concentration of 0.1 ng / ⁇ l of oligonucleotide in PBS-horse buffer (PBS 3X + 10% horse serum (BioMérieux 55842))
- PBS-horse buffer PBS 3X + 10% horse serum (BioMérieux 55842)
- the plate is incubated for 1 h 37 ° C. and then washed 3 times with 300 ⁇ l of PBST buffer.
- 100 ⁇ l of OPD substrate ortho-phenylenediamine Cambridge Medical Biotechnology ref / 456
- OPD substrate ortho-phenylenediamine Cambridge Medical Biotechnology ref /
- the adaptation of the specific combination of probes tested on the VIDAS machine (BIO MERIEUX-VITEK) was carried out.
- the wall of the microplate well is here replaced by the SPR ("Solid Phase Receptacle") (BIOMERIEUX- VITEK-USA) which is a conical support made from a material called K resin (registered trademark for a butadiene-styrene copolymer ).
- K resin registered trademark for a butadiene-styrene copolymer
- the various reagents are deposited in a strip with several cuvettes and the various stages take place in the SPR which is capable of aspirating and discharging the reagents.
- the sandwich hybridization reaction described in the protocol below takes place on the internal wall of the cone.
- the capture oligonucleotide comprising at its 5 ′ end the ligand Aminolink 2 (Applied Biosystems-ref. 400808) is fixed passively on the internal surface of the SPR, at a concentration of 1 ng / ⁇ l in a volume of 315 ⁇ l of a 4x PBS solution (200 mM sodium phosphate pH 7.0, 600 mM NaCl). After overnight at room temperature or two hours at 37 ° C., the cones are washed twice with a PBS Tween solution, then dried under vacuum
- the strip associated with the VIDAS automaton contains in reagents the reagents necessary for detection, that is to say:
- the contents of the first and second wells are drawn into the pretreated cone as indicated above. After incubation for 30 minutes, the cone is washed twice with a PBS Tween solution and 250 ⁇ l of MUP substrate (4-methyl umbelliferyl phosphate) are aspirated and then released into a reading cuvette The device measures the fluorescent signal expressed in URF ( relative fluorescence units) of the cuvette
- L. mnocua can be detected using the combination of the following two probes for capture and detection, respectively:
- L. ivanovn can be detected using the combination of the following two probes for capture and detection, respectively.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96903065A EP0809710A2 (fr) | 1995-02-08 | 1996-02-07 | Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques |
CA002210769A CA2210769C (fr) | 1995-02-08 | 1996-02-07 | Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques |
JP8524040A JPH11504503A (ja) | 1995-02-08 | 1996-02-07 | 核酸プローブハイブリダイゼーション法を使用するリステリア属細菌の検出 |
US08/875,296 US6090551A (en) | 1995-02-08 | 1996-02-07 | Detection of bacteria of genus Listeria using nucleic probe hybridization techniques |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR95/01431 | 1995-02-08 | ||
FR9501431A FR2730234B1 (fr) | 1995-02-08 | 1995-02-08 | Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996024686A2 true WO1996024686A2 (fr) | 1996-08-15 |
WO1996024686A3 WO1996024686A3 (fr) | 1996-09-26 |
Family
ID=9475937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1996/000202 WO1996024686A2 (fr) | 1995-02-08 | 1996-02-07 | Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques |
Country Status (6)
Country | Link |
---|---|
US (1) | US6090551A (fr) |
EP (1) | EP0809710A2 (fr) |
JP (1) | JPH11504503A (fr) |
CA (1) | CA2210769C (fr) |
FR (1) | FR2730234B1 (fr) |
WO (1) | WO1996024686A2 (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020160A1 (fr) * | 1996-11-08 | 1998-05-14 | E.I. Du Pont De Nemours And Company | MARQUEURS GENETIQUES ET PROCEDES DE DETECTION SPECIFIQUES DE LISTERIA MONOCYTOGENES ET AUTRES ESPECES $i(LISTERIA) |
DE19731292A1 (de) * | 1997-07-21 | 1999-01-28 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Nucleinsäuremolekül, Kit und Verwendung |
WO2000052203A2 (fr) * | 1999-03-02 | 2000-09-08 | King's College London | Identification de bacteries |
US6468743B1 (en) * | 1998-05-18 | 2002-10-22 | Conagra Grocery Products Company | PCR techniques for detecting microbial contaminants in foodstuffs |
US6503747B2 (en) | 1998-07-14 | 2003-01-07 | University Of Hawaii | Serotype-specific probes for Listeria monocytogenes |
US6525185B1 (en) | 1998-05-07 | 2003-02-25 | Affymetrix, Inc. | Polymorphisms associated with hypertension |
KR100850193B1 (ko) | 2004-08-28 | 2008-08-04 | 주식회사 진인 | 모든 세균의 감별을 위한 세균 특이적, 속 특이적 및 종특이적 올리고뉴클레오티드, 이를 포함하는 진단 키트, 및이를 이용한 검출 방법 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040005611A1 (en) * | 2002-05-17 | 2004-01-08 | Hyldig-Nielsen Jens J. | PNA probes, probe sets, methods and kits pertaining to the determination of Listeria |
JP2011224020A (ja) * | 2004-11-19 | 2011-11-10 | Hokkaido Univ | 培養併用インサイチューハイブリダイゼーション法により生きている食中毒細菌及び衛生指標細菌群を迅速かつ特異的に計数するための遺伝子プローブ及びその方法(ウエルシュ菌) |
AU2006304721B2 (en) * | 2005-10-17 | 2012-01-19 | Gen-Probe Incorporated | Compositions and methods to detect Legionella pneumophila nucleic acid |
US8609829B2 (en) * | 2005-10-17 | 2013-12-17 | Gen-Probe Incorporated | Compositions and methods to detect Legionella pneumophila nucleic acid |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0314294A2 (fr) * | 1987-09-11 | 1989-05-03 | Amoco Corporation | Détection de listeria |
WO1990008841A1 (fr) * | 1989-02-06 | 1990-08-09 | Gene-Trak Systems | Sondes et procedes ameliores pour la detection de listeria |
EP0480289A1 (fr) * | 1990-10-09 | 1992-04-15 | Roche Diagnostics GmbH | Méthode de détection spécifique de genre et d'espèce de bactéries dans un liquide a prober |
EP0501356A1 (fr) * | 1991-02-28 | 1992-09-02 | Roche Diagnostics GmbH | Détection de bactéries avec amplification d'acides nucléiques |
WO1993004201A1 (fr) * | 1991-08-13 | 1993-03-04 | Amoco Corporation | Oligonucleotides complementaires d'acides nucleiques mycobacteriens |
WO1993011257A2 (fr) * | 1991-11-25 | 1993-06-10 | Boehringer Ingelheim International Gmbh | Procede de triage de substances a effet modulateur d'une voie cellulaire de transmission de signaux dependant d'un recepteur |
WO1995003412A2 (fr) * | 1993-07-23 | 1995-02-02 | Bio Merieux | Fragment nucleotidique de l'arn ribosomique 23s de mycobacteries, sondes et amorces derivees, reactif et procede de detection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988003957A1 (fr) * | 1986-11-24 | 1988-06-02 | Gen-Probe Incorporated | Sondes d'acide nucleique pour la detection et/ou la quantification d'organismes non viraux |
CA1317535C (fr) * | 1987-06-30 | 1993-05-11 | Nanibhushan Dattagupta | Essai de sequences a l'aide de genes amplifies |
DE4340193B4 (de) * | 1993-11-25 | 2004-02-26 | Dürr Dental GmbH & Co. KG | Saugeinheit für dentale Zwecke |
-
1995
- 1995-02-08 FR FR9501431A patent/FR2730234B1/fr not_active Expired - Fee Related
-
1996
- 1996-02-07 WO PCT/FR1996/000202 patent/WO1996024686A2/fr not_active Application Discontinuation
- 1996-02-07 US US08/875,296 patent/US6090551A/en not_active Expired - Fee Related
- 1996-02-07 JP JP8524040A patent/JPH11504503A/ja active Pending
- 1996-02-07 CA CA002210769A patent/CA2210769C/fr not_active Expired - Fee Related
- 1996-02-07 EP EP96903065A patent/EP0809710A2/fr not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0314294A2 (fr) * | 1987-09-11 | 1989-05-03 | Amoco Corporation | Détection de listeria |
WO1990008841A1 (fr) * | 1989-02-06 | 1990-08-09 | Gene-Trak Systems | Sondes et procedes ameliores pour la detection de listeria |
EP0480289A1 (fr) * | 1990-10-09 | 1992-04-15 | Roche Diagnostics GmbH | Méthode de détection spécifique de genre et d'espèce de bactéries dans un liquide a prober |
EP0501356A1 (fr) * | 1991-02-28 | 1992-09-02 | Roche Diagnostics GmbH | Détection de bactéries avec amplification d'acides nucléiques |
WO1993004201A1 (fr) * | 1991-08-13 | 1993-03-04 | Amoco Corporation | Oligonucleotides complementaires d'acides nucleiques mycobacteriens |
WO1993011257A2 (fr) * | 1991-11-25 | 1993-06-10 | Boehringer Ingelheim International Gmbh | Procede de triage de substances a effet modulateur d'une voie cellulaire de transmission de signaux dependant d'un recepteur |
WO1995003412A2 (fr) * | 1993-07-23 | 1995-02-02 | Bio Merieux | Fragment nucleotidique de l'arn ribosomique 23s de mycobacteries, sondes et amorces derivees, reactif et procede de detection |
Non-Patent Citations (2)
Title |
---|
FEMS MICROBIOLOGY LETTERS, vol. 96, Septembre 1992, pages 219-224, XP002008632 THOMPSON, D ET AL : "studies on the ribosomal RNA operons of Listeria monocytogenes" * |
SYSTEMATIC AND APPLIED MICROBIOLOGY, vol. 15, 1992, pages 487-501, XP002008633 LUDWIG, W ET AL: "complete 23S Ribosomal RNA sequences of gram positive bacteria with a low DNA G+C content" * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020160A1 (fr) * | 1996-11-08 | 1998-05-14 | E.I. Du Pont De Nemours And Company | MARQUEURS GENETIQUES ET PROCEDES DE DETECTION SPECIFIQUES DE LISTERIA MONOCYTOGENES ET AUTRES ESPECES $i(LISTERIA) |
DE19731292A1 (de) * | 1997-07-21 | 1999-01-28 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Nucleinsäuremolekül, Kit und Verwendung |
US6525185B1 (en) | 1998-05-07 | 2003-02-25 | Affymetrix, Inc. | Polymorphisms associated with hypertension |
US6468743B1 (en) * | 1998-05-18 | 2002-10-22 | Conagra Grocery Products Company | PCR techniques for detecting microbial contaminants in foodstuffs |
US6503747B2 (en) | 1998-07-14 | 2003-01-07 | University Of Hawaii | Serotype-specific probes for Listeria monocytogenes |
WO2000052203A2 (fr) * | 1999-03-02 | 2000-09-08 | King's College London | Identification de bacteries |
WO2000052203A3 (fr) * | 1999-03-02 | 2000-12-28 | King S College London | Identification de bacteries |
AU776981B2 (en) * | 1999-03-02 | 2004-09-30 | Guy's & St. Thomas's National Health Service Trust | Identification of bacteria by amplification and probing |
US9109260B1 (en) | 1999-03-02 | 2015-08-18 | King's College London | Identification of bacteria by amplification and probing |
KR100850193B1 (ko) | 2004-08-28 | 2008-08-04 | 주식회사 진인 | 모든 세균의 감별을 위한 세균 특이적, 속 특이적 및 종특이적 올리고뉴클레오티드, 이를 포함하는 진단 키트, 및이를 이용한 검출 방법 |
Also Published As
Publication number | Publication date |
---|---|
US6090551A (en) | 2000-07-18 |
EP0809710A2 (fr) | 1997-12-03 |
CA2210769C (fr) | 2002-09-24 |
WO1996024686A3 (fr) | 1996-09-26 |
CA2210769A1 (fr) | 1996-08-15 |
FR2730234B1 (fr) | 1997-03-28 |
FR2730234A1 (fr) | 1996-08-09 |
JPH11504503A (ja) | 1999-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2134113A1 (fr) | Procede de destabilisation d'une structure secondaire intracatenaire d'un polynucleotide simple brin, et de capture dudit polynucleotide | |
FR2694754A1 (fr) | Fragments d'ADN de mycobactéries, amorces d'amplification, sondes d'hybridation, réactifs et procédé de détection de détection de mycobactéries. | |
CA2174753C (fr) | Fragments nucleotidiques capables de s'hybrider specifiquement a l'adnr ou arnr des rickettsia et leur utilisation comme sondes ou amorces | |
FR2709310A1 (fr) | Fragment nucléotidique de l'ARN ribosomique 23S de mycobactéries, sondes et amorces dérivées, réactif et procédé de détection. | |
WO1996024686A2 (fr) | Detection de bacteries du genre listeria selon des techniques d'hybridation de sondes nucleiques | |
EP0490951B1 (fr) | Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments | |
EP0763602B1 (fr) | Détection des Entérobactéries | |
FR2883298A1 (fr) | Fragments d'acides nucleiques et methode de detection specifique par identification moleculaire de differentes especes de bacteries du genre acinetobacter | |
EP0577523B1 (fr) | Fragment de l'ADN génomique de Streptococcus pneumoniae, sonde d'hybridation, amorce d'amplification, réactif et procédé de détection de Streptococcus pneumoniae | |
EP1558637B1 (fr) | Identification moleculaire des bacteries du genre streptococcus et genres apparentes | |
FR2694768A1 (fr) | Séquences d'oligonucléotides pour la détection spécifique de mollicutes par amplication de gènes conservés. | |
EP1458894A2 (fr) | Procede de detection et/ou d identification de l espece animale d origine de la matiere animale contenue dans un echantillon | |
FR2733755A1 (fr) | Fragment nucleotidique de l'arn ribosomique 16s de corynebacteries, sondes et amorces derivees, reactif et procede de detection | |
WO1998055646A1 (fr) | Fragment nucleotidique de l'arn 23s de bacteries du genre chlamydia, utlisations comme sonde, amorce, et dans un reactif et un procede de detection | |
EP1254253B1 (fr) | Oligonucleotides monocatenaires, sondes, amorces et procede de detection des spirochetes | |
EP2094865B1 (fr) | Procede d'identification moleculaire et genotypage des bacteries du complexe mycobacterium tuberculosis | |
FR2616804A1 (fr) | Sonde d'adn destinee a la detection de listeria monocytogenes, kit analytique et methode permettant d'effectuer cette detection | |
JP2002524089A (ja) | オリゴヌクレオチド(Oligonukleotide)、核酸の増幅、及び/又は、−ハイブリダイゼション(−Hybridizing)によるリステリア・モノチトゲネス(ListeriaMonocytogenes/L.Monocytogenes)の検出法とそのためのキット。 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2210769 Country of ref document: CA Ref country code: CA Ref document number: 2210769 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 524040 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996903065 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08875296 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1996903065 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996903065 Country of ref document: EP |